STOCK TITAN

MiniMed Group (MMED) SVP granted time-vested RSU stock awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MiniMed Group, Inc. senior vice president and general counsel Courtney Nelson reported equity compensation grants of common stock on July 1, 2026. The Form 4 shows two awards totaling 22,057 and 60,730 shares, each recorded at $0.00 per share as compensation rather than open-market purchases.

Footnotes state these represent restricted stock units granted under the 2026 Long Term Incentive Plan. One grant vests in roughly equal one-third installments on the first, second and third anniversaries of the grant date, while the other vests on the third anniversary. Following these awards, the filing reports updated direct holdings of 138,146 and 116,089 common shares in the respective lines, including shares issuable upon RSU vesting and 296 shares acquired via the 2026 Employee Stock Purchase Plan.

Positive

  • None.

Negative

  • None.
Insider Wills Courtney Nelson
Role SVP, Gen. Counsel, Corp. Sec.
Type Security Shares Price Value
Grant/Award Common Stock 60,730 $0.00 --
Grant/Award Common Stock 22,057 $0.00 --
Holdings After Transaction: Common Stock — 116,089 shares (Direct, null)
Footnotes (1)
  1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Includes 296 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date.
RSU grant 1 22,057 shares Common stock grant on July 1, 2026 at $0.00 per share
RSU grant 2 60,730 shares Common stock grant on July 1, 2026 at $0.00 per share
Holdings after grant line 1 138,146 shares Total common shares following first reported grant
Holdings after grant line 2 116,089 shares Total common shares following second reported grant
ESPP acquisition 296 shares Shares acquired under 2026 Employee Stock Purchase Plan on June 30, 2026
Transaction count 2 acquisitions Both non-derivative grants coded A for grant/award acquisition
restricted stock units ("RSUs") financial
"Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2026 MiniMed Group, Inc. Long Term Incentive Plan financial
"Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan"
Employee Stock Purchase Plan financial
"Includes 296 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did MiniMed Group (MMED) disclose in this Form 4 filing?

MiniMed Group reported equity compensation grants to SVP and general counsel Courtney Nelson. Two awards of common stock were recorded as grants at $0.00 per share, reflecting restricted stock unit awards under the 2026 Long Term Incentive Plan, not open-market purchases.

How many MiniMed (MMED) shares were granted to Courtney Nelson?

The filing shows grants of 22,057 and 60,730 shares of MiniMed common stock. These are structured as restricted stock unit awards that vest over time, rather than immediate, fully unrestricted shares, aligning compensation with longer-term service and performance at the company.

How do the MiniMed (MMED) RSU grants vest over time?

One RSU grant vests in approximately equal one-third increments on the first, second, and third anniversaries of the July 1, 2026 grant date. The other grant vests entirely on the third anniversary, creating a multi-year vesting schedule tied to continued service.

Are these MiniMed (MMED) transactions open-market insider buys or sales?

No, they are not open-market trades. The Form 4 labels both transactions with code “A” as grants or awards at $0.00 per share, indicating restricted stock unit-based compensation rather than discretionary market purchases or sales of MiniMed common stock by the executive.

What are Courtney Nelson’s reported MiniMed (MMED) holdings after these grants?

After the reported grants, the Form 4 lists 138,146 and 116,089 MiniMed common shares following the respective transactions. These figures include shares to be issued upon RSU vesting and 296 shares acquired through the 2026 Employee Stock Purchase Plan on June 30, 2026.

What plans are referenced in MiniMed (MMED) SVP’s Form 4 footnotes?

Footnotes reference the 2026 MiniMed Group, Inc. Long Term Incentive Plan, under which the RSUs were granted, and the 2026 Employee Stock Purchase Plan, through which 296 shares were acquired. These plans outline equity compensation and employee stock purchase mechanics for MiniMed personnel.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wills Courtney Nelson

(Last)(First)(Middle)
C/O MINIMED GROUP, INC.
18000 DEVONSHIRE STREET

(Street)
NORTHRIDGE CALIFORNIA 91325

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Gen. Counsel, Corp. Sec.
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A60,730(1)A$0116,089(2)(3)D
Common Stock07/01/2026A22,057(4)A$0138,146(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date.
2. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.
3. Includes 296 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026.
4. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date.
Remarks:
/s/ Bryan F. Kelly, attorney-in-fact07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)